• Eastman Chemical management commentary reported third-quarter 2026 adjusted EPS of $1.84, up significantly year over year but modestly lower sequentially.
• Revenue fell 5% sequentially as sales volume/mix declined 7%, reflecting seasonal weakness and customer caution.
• Management attributed the sequential earnings decline primarily to escalating Middle East conflict, which increased costs and weakened demand.
• Additives & Functional Products earnings exceeded expectations, while Advanced Materials faced softer demand, operational constraints and raw material cost pressures.
• Management projected full-year 2026 adjusted EPS of $6.00 to $6.20, with operating cash flow of approximately $850 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eastman Chemical Company published the original content used to generate this news brief on October 29, 2026, and is solely responsible for the information contained therein.